Game
-
First Patient Dosed in a Phase III Clinical Study of Anti-HER2 Biparatopic ADC JSKN003 for the Treatment of HER2-positive Breast Cancer
SUZHOU,China,Feb. 27,2025-- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical Group Co.,Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that the first patient has been su
02-28
Details -
Minesto publishes Year-End Report 2024
GOTHENBURG,Sweden,Feb. 27,2025-- CEO Dr. Martin Edlund: "Minesto has now demonstrated competitive renewable energy production from an untapped natural resource based on a truly novel and propriet
02-28
Details -
Metabolon Unveils New Multiomics Biomarker Discovery Functionality via its Industry-leading Integrated Bioinformatics Platform
Metabolon\'s expertise extends beyond metabolomics to include data insights and software solutions for multiomics research
02-28
Details -
Silverfort Stakes Its Claim in Identity Security with Patented Architecture and Rebrand, as Demand for the Market Accelerates
Introducing Runtime Access Protection (RAP) enabling the first end-to-end identity security platform,securing every identity across hybrid environments and disrupting siloed categories like NHI,PAM,M
02-28
Details -
Mexico Reaches Record 35.1 Million Vehicles in Operation, Reveals Integrate Data Facts (IDF)
ROCHESTER HILLS,Mich.,Feb. 28,2025-- Integrate Data Facts (IDF) today announced the results of its 2024 year-end Vehicles in Operation (VIO) study for Mexico,revealing a record-breaking 35.1 million
02-28
Details -
New Canopus SEER Platform Gives Ultimate Control over Data Powering AI Agents
Agentic-AI,real-time network observability platform with programmable sensors and curated data streams enables network teams to see every user and application experiencein Ultra-HD clarity
02-28
Details -
AIR INDIA IMPROVES CONNECTIVITY FROM SINGAPORE TO EUROPE VIA INDIA
Air India offers enhanced connectivity from Singapore to European destinations such as London Heathrow,Frankfurt,Paris,Amsterdam via India,reducing connection times to around 2 hours
02-27
Details -
Tuya Reports Fourth Quarter and Fiscal 2024 Unaudited Financial Results and Declaration of Dividend
SANTA CLARA,Calif.,Feb. 26,2025-- Tuya Inc. ("Tuya" or the "Company") (NYSE: TUYA; HKEX: 2391),a global leading AI cloud platform service provider,today announced its unaudited fin
02-27
Details -
Lunit Announces Leadership Transition at Volpara: Craig Hadfield Appointed CEO
SEOUL,South Korea and WELLINGTON,New Zealand,Feb. 26,2025-- Lunit (KRX:328130.KQ),a leading provider of AI-powered solutions for cancer diagnostics and therapeutics,today announced the appointment of
02-27
Details -
WuXi Biologics Again Passed GMP Inspection by Japan PMDA
WUXI,China,Feb. 27,2025-- WuXi Biologics ("WuXi Bio") (2269.HK),a leading global Contract Research,Development,and Manufacturing Organization (CRDMO),today announced that it has again passed
02-27
Details
